Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Ligand Pharmaceuticals (LGND) over the last 16 years, with Q3 2025 value amounting to 60.36.

  • Ligand Pharmaceuticals' Interest Coverage Ratio rose 132314.76% to 60.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 4.6, marking a year-over-year increase of 16420.01%. This contributed to the annual value of 7.44 for FY2024, which is 14088.89% down from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Interest Coverage Ratio of 60.36 as of Q3 2025, which was up 132314.76% from 7.32 recorded in Q2 2025.
  • Over the past 5 years, Ligand Pharmaceuticals' Interest Coverage Ratio peaked at 3078.0 during Q3 2023, and registered a low of 83.75 during Q4 2022.
  • Its 5-year average for Interest Coverage Ratio is 164.63, with a median of 4.24 in 2024.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first tumbled by 109210.7% in 2022, then soared by 818049.59% in 2023.
  • Quarter analysis of 5 years shows Ligand Pharmaceuticals' Interest Coverage Ratio stood at 8.44 in 2021, then plummeted by 1092.11% to 83.75 in 2022, then soared by 69.39% to 25.63 in 2023, then surged by 57.42% to 10.91 in 2024, then skyrocketed by 653.09% to 60.36 in 2025.
  • Its Interest Coverage Ratio stands at 60.36 for Q3 2025, versus 7.32 for Q2 2025 and 41.77 for Q1 2025.